Sign in

CIK 0000059478

  • Large accelerated filer

ELI LILLY & Co

Sign in to watch
Ticker
LLY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
IN
Entity type
Operating
EIN
350470950
Phone
+1 317-276-2000
Business address
LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$7,012,600
in 1 filing, $7.0M under 10b5-1 plans

Net −$7,012,600. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Hakim Anat −$7.0M EVP, GC & Secretary sold 55% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-02-10 White Anne E. EVP & Pres, Lilly Neuroscience Grant or award +6,828.87 $868.88 $5.9M 74,209.77
2025-02-10 White Anne E. EVP & Pres, Lilly Neuroscience Grant or award · Restricted Stock Unit +3,572 3,572
2025-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Exercise or conversion +3,269 68,838
2025-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Shares withheld for taxes −1,457.1 $811.08 $1.2M 67,380.9
2025-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Exercise or conversion · Restricted Stock Unit −3,269 0
2024-02-12 White Anne E. EVP & Pres, Lilly Neuroscience Grant or award +5,363 $737.26 $4.0M 65,569
2024-02-12 White Anne E. EVP & Pres, Lilly Neuroscience Grant or award · Restricted Stock Unit +3,269 3,269
2024-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Exercise or conversion +4,124 62,050
2024-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Shares withheld for taxes −1,844 $645.61 $1.2M 60,206
2024-02-01 White Anne E. EVP & Pres, Lilly Neuroscience Exercise or conversion · Restricted Stock Unit −4,124 0

Page 1 of 1 · 10 trades